BIOPHARMA
ByWill Novo Nordisk Pull Ahead of Eli Lilly with FDA Approval of Oral Wegovy?
The U.S. Food and Drug Administration (FDA) has approved the first daily oral version of the obesity drug…
Is Tanya Alcorn Poised to Transform Pfizer’s Global Hospital and Biosimilars Strategy?
Pfizer has appointed Tanya Alcorn as President, Global Hospital and Biosimilars, expanding her leadership responsibilities after serving more…
Is Pfizer Facing New Safety Scrutiny After Reporting a Patient Death in Its Hympavzi Hemophilia Trial?
Pfizer has disclosed that a patient enrolled in a clinical trial evaluating its investigational hemophilia treatment Hympavzi died…
How Is Pfizer Expanding Its Oncology Pipeline Through T-Cell–Targeted Immunotherapy for Prostate Cancer?
Cambridge, Massachusetts Pfizer is strengthening its oncology research pipeline through a new program launched under its strategic collaboration…
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital platform designed to…
Is Sanofi Strengthening Its Adult Vaccine Strategy with a $2.2 Billion Dynavax Deal?
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by announcing a $2.2…
